Paper30730552
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Nicolosi P and 8 others. JAMA Oncol, 2019. Cited by 302 papers, by iCite.
Cite this record
ConductScience Library. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines. Papers, record 30730552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30730552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Predisposition to Disease | Major topic |
| Germ-Line Mutation | Major topic |
| Prostatic Neoplasms | Major topic |
| Aged | |
| Cross-Sectional Studies | |
| Genetic Testing | |
| Guidelines as Topic | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24484606 | Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study. | Eur Urol | 2014 | https://conductscience.org/library/papers/24484606 | PubMed |
| 2 | 24556621 | Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24556621 | PubMed |
| 3 | 29236593 | Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29236593 | PubMed |
| 4 | 25394175 | A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. | Genet Med | 2015 | https://conductscience.org/library/papers/25394175 | PubMed |
| 5 | 29512888 | The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine. | Am J Med Genet C Semin Med Genet | 2018 | https://conductscience.org/library/papers/29512888 | PubMed |
| 6 | 28608931 | The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. | Cancer | 2017 | https://conductscience.org/library/papers/28608931 | PubMed |
| 7 | 27581128 | A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital. | Breast Cancer Res Treat | 2016 | https://conductscience.org/library/papers/27581128 | PubMed |
| 8 | 27433846 | Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27433846 | PubMed |
| 9 | 28767289 | Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28767289 | PubMed |
| 10 | 26000489 | Integrative clinical genomics of advanced prostate cancer. | Cell | 2015 | https://conductscience.org/library/papers/26000489 | PubMed |
| 11 | 26207792 | A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients. | J Mol Diagn | 2015 | https://conductscience.org/library/papers/26207792 | PubMed |
| 12 | 23569316 | Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23569316 | PubMed |
| 13 | 27989354 | Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. | Eur Urol | 2017 | https://conductscience.org/library/papers/27989354 | PubMed |
| 14 | 28492532 | Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. | Genet Med | 2017 | https://conductscience.org/library/papers/28492532 | PubMed |
| 15 | 28448241 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28448241 | PubMed |
| 16 | 25454609 | Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer. | Eur Urol | 2015 | https://conductscience.org/library/papers/25454609 | PubMed |
| 17 | 27242960 | Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review. | Front Oncol | 2016 | https://conductscience.org/library/papers/27242960 | PubMed |
Cited by187
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 302 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42886888 | Plasma-Derived Genomic Instability Status and Rucaparib Outcomes in Metastatic Castration-Resistant Prostate Cancer: TRITON2. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/42886888 | PubMed |
| 42842178 | Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42842178 | PubMed |
| 42650149 | Population-Specific Genetic Markers of Prostate Cancer Risk in Kazakh Men: Association Analysis of 102 SNPs and Risk Prediction Modeling. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42650149 | PubMed |
| 42578161 | Germline HOXB13 G84E Variant in a Patient with Gastric and Prostate Cancer: A Case Report and Literature Review. | Case Rep Oncol | 2026 | https://conductscience.org/library/papers/42578161 | PubMed |
| 42565081 | Clinical Impact of Germline Pathogenic Variants in High-risk Prostate Cancer Treated with Radiotherapy. | Eur Urol Open Sci | 2026 | https://conductscience.org/library/papers/42565081 | PubMed |
| 42507335 | SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026). | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42507335 | PubMed |
| 42502690 | Identifying and characterizing the germinal genetic landscape of men with prostate cancer: A real-life, retrospective, multicenter study. | Genet Med Open | 2026 | https://conductscience.org/library/papers/42502690 | PubMed |
| 42488705 | Early-Onset Prostate Cancer: Epidemiology, Risk Factors, Biology, Clinical Features, Management, and Early Detection. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42488705 | PubMed |
| 42449576 | Implementation of Genetic Testing in Prostate Cancer: A Real-World Survey of Outpatient Urologists in Germany (PRO-GEN). | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449576 | PubMed |
| 42438725 | The distinct molecular profile of metastatic prostate cancer in the mixed Brazilian population. | Genet Med Open | 2026 | https://conductscience.org/library/papers/42438725 | PubMed |
| 42415575 | Understanding the utilization of genetic counseling and testing among patients with prostate cancer. | Can J Urol | 2026 | https://conductscience.org/library/papers/42415575 | PubMed |
| 42232598 | Identification of BRCA2 Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas. | Oncol Res | 2026 | https://conductscience.org/library/papers/42232598 | PubMed |
| 42007214 | Exploring the genetic overlap between obstructive sleep apnea and prostate cancer. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/42007214 | PubMed |
| 42001130 | Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology. | Genome Med | 2026 | https://conductscience.org/library/papers/42001130 | PubMed |
| 41623173 | Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41623173 | PubMed |
| 41579216 | Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how? | Fam Cancer | 2026 | https://conductscience.org/library/papers/41579216 | PubMed |
| 41561489 | Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study. | Eur Urol Open Sci | 2026 | https://conductscience.org/library/papers/41561489 | PubMed |
| 41541272 | Predictive Genetic Testing in the Cancer Management and Prevention. | J Cancer Sci Clin Ther | 2025 | https://conductscience.org/library/papers/41541272 | PubMed |
| 41440226 | Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications. | Curr Oncol | 2025 | https://conductscience.org/library/papers/41440226 | PubMed |
| 41353608 | Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns. | Prostate | 2026 | https://conductscience.org/library/papers/41353608 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| HOXB13 | 10481 | PubTator's text mining | https://conductscience.org/library/genes/10481 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30730552
GET https://conductscience.org/api/papers/v1/30730552/cited_by?page=2